Pfizer’s CEO Cashes Out On 62% Of His Stock On Coronavirus Vaccine Announcement
The head of Pfizer sold 62% of his stock in the company at the same time he announced the Covid-19 vaccine trial results.
Alberta Bourla sold $5.6 million in stock this week as part of a pre-agreed trade plan adopted on August 19. The…